|
Volumn 41, Issue 3, 2014, Pages 345-347
|
Targeting Foxp1 for reinstating anticancer immunosurveillance
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD4 ANTIGEN;
FOXP1 PROTEIN;
GAMMA INTERFERON;
GRANZYME B;
INTERLEUKIN 15;
INTERLEUKIN 17;
INTERLEUKIN 2;
INTERLEUKIN 23;
INTERLEUKIN 6;
INTERLEUKIN 7;
PROSTAGLANDIN E2;
PROTEIN;
SMAD2 PROTEIN;
SMAD3 PROTEIN;
STROMAL CELL DERIVED FACTOR 1;
TRANSFORMING GROWTH FACTOR BETA;
UNCLASSIFIED DRUG;
VASCULOTROPIN A;
FORKHEAD TRANSCRIPTION FACTOR;
FOXP1 PROTEIN, MOUSE;
REPRESSOR PROTEIN;
CD8+ T LYMPHOCYTE;
CYTOTOXIC T LYMPHOCYTE;
DEGRANULATION;
ENHANCER REGION;
HUMAN;
IMMUNE RESPONSE;
IMMUNOSURVEILLANCE;
NONHUMAN;
PROTEIN DNA INTERACTION;
PROTEIN EXPRESSION;
PROTEIN PROTEIN INTERACTION;
PROTEIN TARGETING;
SHORT SURVEY;
T LYMPHOCYTE;
T LYMPHOCYTE ACTIVATION;
TUMOR MICROENVIRONMENT;
UPREGULATION;
ANIMAL;
FEMALE;
IMMUNOLOGY;
NEOPLASM;
TUMOR ESCAPE;
ANIMALS;
FEMALE;
FORKHEAD TRANSCRIPTION FACTORS;
NEOPLASMS;
REPRESSOR PROTEINS;
T-LYMPHOCYTES, CYTOTOXIC;
TRANSFORMING GROWTH FACTOR BETA;
TUMOR ESCAPE;
|
EID: 84908014569
PISSN: 10747613
EISSN: 10974180
Source Type: Journal
DOI: 10.1016/j.immuni.2014.09.001 Document Type: Short Survey |
Times cited : (3)
|
References (10)
|